Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 15, 2020Frontiers in Cellular and Infection MicrobiologyOpen Access

Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity

View Full Paper
Ask AI
Bookmark
Share

Authors

SPShabi ParvezGYGanesh YadagiriAKArchana Karole

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Parvez et al. (2020) studied this question.

synapsesocial.com/papers/6a64d92cfbcda00b806442fehttps://doi.org/10.3389/fcimb.2020.570573
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Utilization of solid lipid nanoparticles for enhanced delivery of curcumin in cocultures of HT29-MTX and Caco-2 cells2013 · 89 citations
  2. 2Solid lipid nanoparticles produced through a coacervation method2010 · 110 citations
  3. 3Development of targeted 1,2-diacyl-sn-glycero-3-phospho- l -serine-coated gelatin nanoparticles loaded with amphotericin B for improvedin vitroandin vivoeffect in leishmaniasis2014 · 46 citations